➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
Moodys
AstraZeneca
McKesson
Dow
Express Scripts

Last Updated: July 3, 2020

DrugPatentWatch Database Preview

Details for Patent: 7,598,279


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Which drugs does patent 7,598,279 protect, and when does it expire?

Patent 7,598,279 protects XCOPRI and is included in one NDA.

This patent has twenty-two patent family members in eighteen countries.

Summary for Patent: 7,598,279
Title:Neurotherapeutic azole compounds
Abstract: Azole compounds containing carbamoyl group and pharmaceutically useful salts thereof are described. The compounds are effective anticonvulsants which are used in the treatment of disorders of the central nervous system, especially as anxiety, depression, convulsion, epilepsy, migraine, bipolar disorder, drug abuse, smoking, ADHD, obesity, sleep disorder, neuropathic pain, stroke, cognitive impairment, neurodegeneration, stroke and muscle spasm.
Inventor(s): Choi; Yong Moon (Pinebrook, NJ), Kim; Choon-Gil (Daejon, KR), Yi; Han-Ju (Daejeon, KR), Kang; Young-Sun (Daejeon, KR), Lee; Hyun-Seok (Daejeon, KR)
Assignee: SK Holdings Co., Ltd. (Seoul, KR)
Application Number:11/407,526
Patent Claim Types:
see list of patent claims
Compound;

Recent additions to Drugs Protected by US Patent 7,598,279

These patents are from the daily update and have not yet been integrated into the regular database
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Product Substance Delist Req. Patent Expiration Usecode Patented / Exclusive Use
Sk Life XCOPRI cenobamate TABLET 212839 Mar 10, 2020 RX Yes   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Type >RLD >Patent No. >Product >Substance >Delist Req. >Patent Expiration >Usecode >Patented / Exclusive Use

Drugs Protected by US Patent 7,598,279

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Sk Life XCOPRI cenobamate TABLET;ORAL 212839-001 Mar 10, 2020 RX Yes No   Start Trial   Start Trial Y   Start Trial
Sk Life XCOPRI cenobamate TABLET;ORAL 212839-002 Mar 10, 2020 RX Yes No   Start Trial   Start Trial Y   Start Trial
Sk Life XCOPRI cenobamate TABLET;ORAL 212839-003 Mar 10, 2020 RX Yes No   Start Trial   Start Trial Y   Start Trial
Sk Life XCOPRI cenobamate TABLET;ORAL 212839-004 Mar 10, 2020 RX Yes No   Start Trial   Start Trial Y   Start Trial
Sk Life XCOPRI cenobamate TABLET;ORAL 212839-005 Mar 10, 2020 RX Yes No   Start Trial   Start Trial Y   Start Trial
Sk Life XCOPRI cenobamate TABLET;ORAL 212839-006 Mar 10, 2020 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 7,598,279

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 053065   Start Trial
Australia 2006237798   Start Trial
Brazil PI0607529   Start Trial
Canada 2606258   Start Trial
China 101228138   Start Trial
Denmark 1879873   Start Trial
European Patent Office 1879873   Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Moodys
Colorcon
Johnson and Johnson
Harvard Business School
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.